Morgan Stanley Lists Ethereum and Solana ETFs on NYSE Arca

Morgan Stanley Investment Management has launched exchange-traded funds providing exposure to Ethereum and Solana, giving investors access to two of the largest crypto networks through a traditional asset manager. The rollout is tied to a registration filed with U.S. regulators, reflected in an amended Form S-1/A posted on SEC.gov. The launch builds on the firm's earlier push into spot Bitcoin products, which helped establish a blueprint for expanding into additional digital assets. Why Ethereum and Solana in One Lineup Packaging Ethereum and Solana in the same offering underscores institutional demand extending beyond Bitcoin and into major altcoins. Ethereum continues to lead as the dominant smart-contract platform, while Solana has emerged as a closely watched high-throughput rival, often positioned as the alternative bet in investor portfolios. The funds use the same 0.14% fee structure Morgan Stanley applied to its prior crypto products, aligning costs across its broader digital-asset ETF lineup. For many allocators, the single-issuer structure also simplifies access to altcoin exposure by avoiding the operational burden of wallets, private keys, and direct on-chain custody. What the NYSE Arca Listing Indicates The NYSE Arca listing links an established Wall Street brand to exchange-traded crypto exposure and enables trading through standard brokerage accounts. That distribution channel has been a key adoption driver for traditional finance clients, offering the visibility and convenience that often determine whether a new product gains traction. Key metrics to watch include trading volumes, net flows, and whether Morgan Stanley broadens the range with additional altcoin funds. The venue and issuer are now in place; investor demand will determine how significant this expansion becomes. Disclaimer: This article is for informational purposes only and does not constitute financial or investment advice. Cryptocurrency and digital asset markets carry significant risk. Always do your own research before making decisions.